<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03984175</url>
  </required_header>
  <id_info>
    <org_study_id>1050867</org_study_id>
    <nct_id>NCT03984175</nct_id>
  </id_info>
  <brief_title>Clinical Decision Support for Mechanical Ventilation of Patients With ARDS</brief_title>
  <official_title>Implementation of Computerized Clinical Decision Support for Mechanical Ventilation of Patients With Acute Respiratory Distress Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intermountain Health Care, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>McKay-Dee Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Utah Valley Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dixie Regional Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Intermountain Health Care, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Perform a pilot study of quality improvement interventions for critical care physicians
      (intensivists) and respiratory therapists (RTs) to improve application of low tidal volume
      mechanical ventilation (LTVV) for patients with the acute respiratory distress syndrome
      (ARDS) using the computerized mechanical ventilation protocols currently available in the
      investigator's Cerner electronic health record (EHR).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A multidisciplinary team of implementation researchers and clinical effectiveness researchers
      has been assembled to adapt the Consolidated Framework for Implementation Research (CFIR) for
      this planning study. The team identified the baseline clinical care delivery for LTVV in
      patients with ARDS across Intermountain hospitals and identified the barriers and
      facilitators to this standard of care. This pilot implementation study will focus on a Pilot
      Solution aimed at achieving ideal clinical care delivery of LTVV for patients with ARDS.

      Abbreviations for Mechanical Ventilation:

      PEEP: positive end expiratory pressure FIO2: fraction of inspired oxygen CPAP: continuous
      positive airway pressure PS: pressure support VC: volume control VC+: hybrid mode for volume
      targeted ventilation on Puritan Bennett ventilators PRVC: pressure regulated volume control,
      hybrid mode for volume targeted ventilation on Draeger ventilators PF ratio: ratio of partial
      pressure of arterial oxygen (PaO2 mmHg) divided by the FIO2 expressed in liters
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 8, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Before and After Comparison</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LTVV Compliance</measure>
    <time_frame>through study completion - 6 months</time_frame>
    <description>Defined as: % of time each patient is on a compliant tidal volume for the duration of mechanical ventilation.
Measured as: VC, PRVC, or VC+ with volume set to 6.5 ml/kg or less for each patient (proportion of mechanically ventilated hours, excluding hours on appropriate CPAP/PS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PEEP FI02 Compliance (continuous variable)</measure>
    <time_frame>through study completion - 6 months</time_frame>
    <description>Defined as: % of time each patient is on a compliant FI02 and PEEP combination.
Measured as: using recommended (per most recently run oxygenation protocol) PEEP-FIO2 combinations, (proportion of ventilated hours, excluding the first four hours of mechanical ventilation and excluding hours on appropriate CPAP/PS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Utilization of Ventilation Protocol (continuous)</measure>
    <time_frame>through study completion - 6 months</time_frame>
    <description>Defined as: % of time each patient is managed with the computerized ventilation protocol.
Measured as: Running the computerized ventilation protocol whenever a ventilator check is performed and an arterial blood gas was done within the previous hour, excluding hours on appropriate CPAP/PS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Utilization of Oxygenation Protocol (continuous)</measure>
    <time_frame>through study completion - 6 months</time_frame>
    <description>Defined as: % of time each patient is managed with the computerized oxygenation protocol.
Measured as: Running the computerized oxygenation protocol at least every four hours when a ventilator check was performed, excluding hours on appropriate CPAP/PS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LTVV Compliance &gt;90% (binary)</measure>
    <time_frame>through study completion - 6 months</time_frame>
    <description>Defined as: meeting, or not meeting, the target LTVV compliance of &gt;90% for each patient.
Measured as: VC, PRVC, or VC+ with volume set to 6.5 ml/kg or less for 90% or more of mechanically ventilated hours, excluding hours on appropriate CPAP/PS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PEEP FI02 Compliance &gt;70% (binary)</measure>
    <time_frame>through study completion - 6 months</time_frame>
    <description>Defined as: meeting, or not meeting, the target PEEP FI02 compliance of &gt;70% for each patient.
Measured as: Using recommended (per most recently run oxygenation protocol) PEEP-FIO2 combinations for at least 70% of mechanically ventilated hours (excluding the first four hours of mechanical ventilation and excluding hours on appropriate CPAP/PS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-Free Days (VFD) to Day 28</measure>
    <time_frame>through study completion - 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of Patients who do not survive to day 28</measure>
    <time_frame>through study completion - 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients with ARDS at three Intermountain tertiary hospitals</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Implementation of Processes</intervention_name>
    <description>Implementation of processes to improve compliance with low tidal volume ventilation in patients with ARDS using a computerized protocol</description>
    <arm_group_label>Patients with ARDS at three Intermountain tertiary hospitals</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Invasive mechanical ventilation

          2. PF ratio &lt;255

          3. Bilateral infiltrates on chest radiograph (adjudicated by a co-investigator)

          4. Presence of â‰¥1 risk factor for ARDS as determined by review of the HER

        Exclusion Criteria:

          1. Age &lt;18 years

          2. Pulmonary capillary wedge pressure &gt;18 mm Hg if a right heart catheter is present

          3. Prisoner

          4. Known to be pregnant

          5. Death &lt;24 hours from initial intubation

          6. Placed comfort care &lt;24 hours from initial intubation

          7. Mechanically ventilated for &gt;7 days prior to meeting ARDS criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Colin K Grissom, MD</last_name>
    <phone>801-507-6554</phone>
    <email>colin.grissom@imail.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Aston</last_name>
      <phone>801-507-4606</phone>
      <email>valerie.aston@imail.org</email>
    </contact>
    <contact_backup>
      <last_name>Carlos Barbagelata</last_name>
      <phone>801-507-4607</phone>
      <email>carlos.barbagelata@imail.org</email>
    </contact_backup>
    <investigator>
      <last_name>Joseph Bledsoe, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samuel Brown, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lori Carpenter</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Knighton, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Lanspa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scott Narus, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ithan Peltan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rajendu Srivastava, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scott Stevens, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lindsay Leither, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 3, 2019</study_first_submitted>
  <study_first_submitted_qc>June 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2019</study_first_posted>
  <last_update_submitted>June 11, 2019</last_update_submitted>
  <last_update_submitted_qc>June 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ARDS</keyword>
  <keyword>Lung Protective Mechanical Ventilation</keyword>
  <keyword>Clinical Decision Support</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

